[Federal Register Volume 67, Number 100 (Thursday, May 23, 2002)]
[Notices]
[Page 36205]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-13014]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Child Health and Human Development; Notice 
of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Child Health and Human 
Development Special Emphasis Panel, ``Mouse Phenotyping: 
Developmental & Fertility Defects''.
    Date: June 14, 2002.
    Time: 9 AM to 5 PM.
    Agenda: To review and evaluate grant applications.
    Place: The Madison Hotel, 15th and M Street, NW., Washington, DC 
20005.
    Contact Person: Norman Chang, PhD, Scientific Review 
Administrator, Division of Scientific Review, National Institute of 
Child Health and Human Development, National Institutes of Health, 
6100 Executive Blvd., Room 5E03, Bethesda, MD 20892. (301) 496-1485.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistant Program Nos. 93.209, 
Contraception and Infertility Loan Repayment Program; 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research, National 
Institutes of Health, HHS).

    Dated: May 17, 2002.
LaVerne Y. Springfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-13014 Filed 5-22-02; 8:45 am]
BILLING CODE 4140-01-M